162 filings
15-12B
PBTH
PROLOR Biotech, Inc.
26 Sep 13
Securities registration termination
12:00am
EFFECT
PBTH
PROLOR Biotech, Inc.
9 Sep 13
Notice of effectiveness
12:00am
S-8 POS
PBTH
PROLOR Biotech, Inc.
6 Sep 13
Registration of securities for employees (post-effective amendment)
12:00am
POS AM
PBTH
PROLOR Biotech, Inc.
6 Sep 13
Prospectus update (post-effective amendment)
12:00am
S-8 POS
PBTH
PROLOR Biotech, Inc.
6 Sep 13
Registration of securities for employees (post-effective amendment)
12:00am
8-K
iwdv728 ullhtamruyfe
30 Aug 13
Completion of Acquisition or Disposition of Assets
12:00am
25-NSE
yzr 7ke2j3ofnjdy
30 Aug 13
Exchange delisting
12:00am
DEFM14A
lwb7h tt0g
24 Jul 13
Proxy related to merger
12:00am
PRER14A
d69ghvy9m
10 Jul 13
Preliminary revised proxy
12:00am
8-K
9m8n6db7
3 Jul 13
PROLOR BIOTECH TO PRESENT POSITIVE RESULTS FROM PRECLINICAL STUDIESOf
12:00am
425
9pncfr6t ym
3 Jul 13
Business combination disclosure
12:00am
PREM14A
9xs0edvhve6il7ypi
28 Jun 13
Preliminary proxy related to merger
12:00am
8-K
eex5l96pk 3su
17 Jun 13
Regulation FD Disclosure
12:00am
S-8
azlt49ucjw73vj
12 Jun 13
Registration of securities for employees
12:00am
8-K
04vqjzx2jz
7 Jun 13
Departure of Directors or Certain Officers
12:00am
8-K
c1v3pt xorrqy66r
4 Jun 13
PROLOR BIOTECH initiates PIVOTAL phase III trial of ITS Longer-Acting Version of human growth hormone
12:00am
DEFA14A
8w2nzc7 11
4 Jun 13
Additional proxy soliciting materials
12:00am